SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
October 2, 1998
---------------
(Date of Report)
GLOBAL MED TECHNOLOGIES, INC.
----------------------------------------------------
(Exact name of Registrant as specified in its charter)
Colorado 0-22083 84-1116894
- ---------------------------- ---------------------- ------------------
(State or other jurisdiction (Commission File Number) (IRS Employer
of incorporation) Identification No.)
12600 WEST COLFAX, SUITE A-500, LAKEWOOD, CO 80215
--------------------------------------------------
(Address of principal, executive offices including zip code)
(303) 238-2000
--------------
(Registrant's telephone number including area code)
N/A
-----------------------------------------------------------
(Former name or former address, if changed since last report)
<PAGE>
ITEM 4. CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT
On June 19, 1998, the Company filed a Current Report on Form 8-K to report a
change in the Company's certifying accountant pursuant to Item 304(a) of
Regulation S-K. At that time, the successor certifying accountant had not been
determined.
Pursuant to Regulation S-K Item 304 the Company makes the following
representations:
Effective October 2, 1998, the Company has engaged KPMG Peat Marwick LLP as
certifying accountant for the year ending December 31, 1998.
The Company did not consult with KPMG Peat Marwick LLP with regard to any matter
concerning the application of accounting principles to any specific
transactions, either completed or proposed, or the type of audit opinion that
might be rendered with respect to the Company's financial statements prior to
engaging the firm.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this Report to be signed on its behalf by the
undersigned thereunto duly authorized.
Date: October 2, 1998
GLOBAL MED TECHNOLOGIES, INC.
By: /s/ MICHAEL I RUXIN
------------------------------
Michael I. Ruxin
Chief Executive Officer
2
